Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Single Arm, Single Center Phase IV Clinical Trial to Evaluate the Immune Persistence and Safety of Freeze-dried Human Rabies Vaccine (Vero Cell)
Authors not listed
Changchun Zhuoyi Biological Co., Ltd · 2019
Abstract
Evaluation of immune persistence after rabies vaccination in 150 people.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-19 MST
Cite this
APA
Anonymous. (2019). Single Arm, Single Center Phase IV Clinical Trial to Evaluate the Immune Persistence and Safety of Freeze-dried Human Rabies Vaccine (Vero Cell). <em>Changchun Zhuoyi Biological Co., Ltd</em>. https://clinicaltrials.gov/study/NCT05547815
Vancouver
Anonymous. Single Arm, Single Center Phase IV Clinical Trial to Evaluate the Immune Persistence and Safety of Freeze-dried Human Rabies Vaccine (Vero Cell). Changchun Zhuoyi Biological Co., Ltd. 2019.
BibTeX
@misc{anon2019Single,
title = {Single Arm, Single Center Phase IV Clinical Trial to Evaluate the Immune Persistence and Safety of Freeze-dried Human Rabies Vaccine (Vero Cell)},
author = {Anonymous},
journal = {Changchun Zhuoyi Biological Co., Ltd},
year = {2019},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Sinovac Biotech Co., Ltd 2021
Open access · US-GOV
A Randomized, Double-blind and Active-controlled Phase Ⅰ/Ⅲ Clinical Trial to Evaluate Immunogenicity and Safety of Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried, Administered With Different Immunization Schedules in Healthy Individuals Aged 10-60 Years
Ab&B Bio-tech Co., Ltd.JS 2025
Open access · US-GOV
A Phase I/II Clinical Trial With Randomized, Blinded, Controlled Design to Evaluate the Safety and Immunogenicity of the Recombinant Herpes Zoster Vaccine (CHO Cell) in Healthy Populations Aged 40 Years and Older Post -Vaccination
Jiangsu Province Centers for Disease Control and Prevention 2017
Open access · US-GOV
Immunogenicity and Safety of A Lyophilized Purified Human Diploid Cell Rabies Vaccine in Chinese Healthy People Aged 10-60 Years.: A Randomized, Blinded, Phase III Clinical Trial.
Sinovac Biotech Co., Ltd 2022
Open access · US-GOV
An Open, Observational Study to Evaluate the Immunity Persistence of an Inactivated Enterovirus 71 Vaccine (Vero Cell) in Subjects Aged 6 to 71 Months
Immunity 2026
Preprint · OA
Human immune aging clock identifies RUNX1 as a decelerator of T cell senescence
Jiangsu Province Centers for Disease Control and Prevention 2022
Open access · US-GOV